EMA sets out plan to accelerate clinical trials, reduce administrative burden

The European Medicines Agency (EMA) wants to speed up your clinical trials. Through the Accelerating Clinical Trials in the EU (ACT EU) initiative, the EMA and other bodies have set out 10 actions they plan to prioritize in 2022 and 2023 to transform how studies are initiated, designed and run.